EP2191824
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
:
EP einkaleyfi: Þýðing ekki lögð inn:
8.6.2006:
14.3.2012:
09172285.0
:
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
8.6.2006
14.3.2012
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
Kowalski, James:
Belle Mead, NJ, US
:
Lakshman, Jay, Parthiban:
Cedar Knolls, NJ, US
:
Serajuddin, Abu, T. M.:
Flushing, Queens, NY, US
:
Joshi, Yatindra:
Princeton, NJ, US
:
689719 P:
10.6.2005:
US
:
690309 P:
14.6.2005:
US
:
A61K 31/40, A61K 9/22, A61K 9/24